Tenet Healthcare Stock
Tenet Healthcare Stock
There is an upward development for Tenet Healthcare compared to yesterday, with an increase of €6.00 (2.730%).
With 44 Buy predictions and not a single Sell prediction Tenet Healthcare is an absolute favorite of our community.
On the other hand, the target price of 217 € is below the current price of 226.0 € for Tenet Healthcare, so the potential is actually -3.98%.
Pros and Cons of Tenet Healthcare in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Tenet Healthcare vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Tenet Healthcare | 2.730% | -5.172% | 23.596% | 58.273% | 26.437% | 223.529% | 276.326% |
| Chemed Corp. | -0.430% | 3.556% | 9.906% | 29.444% | 28.022% | - | - |
| Molina Healthcare | 0.810% | -5.653% | -17.675% | 21.515% | 13.733% | -39.662% | -28.117% |
| Davita Inc. | -18.400% | -6.039% | -4.633% | 63.780% | 104.894% | 99.919% | 74.945% |
Comments
Tenet Healthcare (THC) had its "overweight" rating reaffirmed by Wells Fargo & Company.
Show more
Ratings data for THC provided by MarketBeat
Tenet Healthcare (THC) had its price target raised by Truist Financial Corporation from $270.00 to $290.00. They now have a "buy" rating on the stock.
Show more
Ratings data for THC provided by MarketBeat
Tenet Healthcare (THC) was given a new $308.00 price target by UBS Group AG. They now have a "buy" rating on the stock.
Show more
Ratings data for THC provided by MarketBeat